Grifols (GIFLF) Acquisitions (2012 - 2020)
Grifols' (GIFLF) quarterly Acquisitions came in at -$130.2 million in Q1 2020, up 75.96% on a YoY basis from -$74.0 million in Q2 2019, and up 59.92% quarter-over-quarter from -$324.9 million in Q4 2019.
Analysis
Grifols (GIFLF) Acquisitions (2012 - 2020) Analysis & Trends
Grifols (GIFLF) has reported Acquisitions for 6 consecutive years, with -$130.2 million the latest figure, recorded in Q1 2020.
- For the quarter ending Q1 2020, Acquisitions rose 75.96% year-over-year to -$130.2 million; the trailing twelve-month figure through Mar 2020 stood at -$615.9 million (down 1380.09% YoY), and the FY2020 full-year result was $2.2 billion, up 763.21% from the prior year.
- Acquisitions improved to -$130.2 million in Q1 2020 per GIFLF's latest filing, from -$324.9 million in the prior quarter.
- Across five years, Acquisitions topped out at $381.1 million in Q4 2018 and bottomed at -$541.8 million in Q1 2019.
- Historically, Acquisitions has averaged -$48.6 million across 4 years, with a median of $21.4 million in 2018.
- The sharpest annual moves came in 2018 and 2019: Acquisitions jumped 289.95% in 2018, then sank 2629.63% in 2019.
- Over 4 years, Acquisitions stood at $97.7 million in 2017, then surged by 289.95% to $381.1 million in 2018, then slumped by 185.27% to -$324.9 million in 2019, then soared by 59.92% to -$130.2 million in 2020.
- According to Business Quant data, Acquisitions over the past three periods registered -$130.2 million, -$324.9 million, and -$541.8 million for Q1 2020, Q4 2019, and Q1 2019 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | 11.21 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | - |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | -130.24 Mn |
| Dec 31, 2019 | -324.92 Mn |
| Mar 31, 2019 | -541.80 Mn |
| Dec 31, 2018 | 381.05 Mn |
| Mar 31, 2018 | 21.42 Mn |
| Dec 31, 2017 | 97.72 Mn |
| Mar 31, 2017 | 156.72 Mn |
| Dec 31, 2014 | 2.75 Mn |
| Dec 31, 2012 | 5.23 Mn |